A prospective randomized study comparing bipolar plasmakinetic transurethral resection of the prostate and monopolar transurethral resection of the prostate for the treatment of Benign Prostatic Hyperplasia: effi cacy, sexual function, Quality of Life, and complications
dc.contributor.author | Otaola-Arca, Hugo | |
dc.contributor.author | Álvarez-Ardura, Manuel | |
dc.contributor.author | Fernández, Mario | |
dc.contributor.author | Molina-Escudero, Roberto | |
dc.contributor.author | Páez-Borda, Álvaro | |
dc.date.accessioned | 2021-08-31T18:11:23Z | |
dc.date.available | 2021-08-31T18:11:23Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Objective: To generate high-quality data comparing the clinical effi cacy and safety profi le between monopolar transurethral resection of the prostate (M-TURP) and bipolar plasmakinetic resection of the prostate (PK-TURP) for benign prostatic hyperplasia (BPH). Materials and Methods: Prospective, randomized, single-blinded study conducted in a tertiary-care public institution (Dec/2014-Aug/2016). Inclusion criteria: prostate of <80g in patients with drug-refractory lower urinary tract symptoms (LUTS), complications derived from BPH, or both. Exclusion criteria: a history of pelvic surgery/radiotherapy, neurogenic bladder dysfunction or documented/suspected prostate carcinoma. Treatment effi cacy evaluated at 1, 3, 6 and 12 months. Effi cacy outcomes: international prostate symptom score (IPSS), quality-of-life (QoL) score, international index of erectile function-5 (IIEF-5), maximum urinary fl ow rate (Qmax), postvoid residual urine (PVRU) volume, and prostate volume (PV). Complications and sequelae also assessed. Comparisons performed with parametric/non-parametric tests. Results: Out of the 100 hundred patients, 84 qualifi ed for the analysis (45 M-TURP/39 PK-TURP). No signifi cant differences found in baseline characteristics or operative data, except for a longer operative time in PK-TURP (MD:7.9min; 95%CI:0.13-15.74; p=0.04). No differences found in IPSS, Qmax or PVRU volume. QoL score at 12 months was higher in PK-TURP (MD:0,9points; 95%CI:0.18-1.64; p=0.01). No differences in sexual function, PV, complications or sequelae were found. This study is “rigorous” (Jadadscale) and has a low risk of bias (Cochrane-Handbook). Conclusions: Based on this controlled trial, there is not signifi cant variation in effectiveness and safety between M-TURP and PK-TURP for the treatment of BPH. The small difference in QoL between PK-TURP and M-TURP at the one-year follow-up is not perceivable by the patients and, therefore, not clinically relevant. | es |
dc.identifier.citation | International Brazilian Journal of Urology, 2021, vol. 47(1): 131-144 | es |
dc.identifier.uri | https://dx.doi.org/10.1590/S1677-5538.IBJU.2019.0766 | es |
dc.identifier.uri | http://hdl.handle.net/11447/4553 | |
dc.language.iso | en | es |
dc.subject | Transurethral Resection of Prostate | es |
dc.subject | Quality of Life | es |
dc.subject | Prostatic Hyperplasia | es |
dc.title | A prospective randomized study comparing bipolar plasmakinetic transurethral resection of the prostate and monopolar transurethral resection of the prostate for the treatment of Benign Prostatic Hyperplasia: effi cacy, sexual function, Quality of Life, and complications | es |
dc.type | Article | es |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- A prospective randomized study comparing bipolar.pdf
- Size:
- 3.65 MB
- Format:
- Adobe Portable Document Format
- Description:
- Texto completo
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: